000069936 001__ 69936
000069936 005__ 20190709135637.0
000069936 0247_ $$2doi$$a10.1371/journal.pone.0193541
000069936 0248_ $$2sideral$$a105016
000069936 037__ $$aART-2018-105016
000069936 041__ $$aeng
000069936 100__ $$0(orcid)0000-0001-7293-701X$$aAguilar-Palacio, Isabel$$uUniversidad de Zaragoza
000069936 245__ $$aRisk factors control for primary prevention of cardiovascular disease in men: Evidence from the Aragon Workers Health Study (AWHS)
000069936 260__ $$c2018
000069936 5060_ $$aAccess copy available to the general public$$fUnrestricted
000069936 5203_ $$aBenefits of cardiovascular disease (CVD) risk factors control are well known, but goals achievement remains low. The objective of this study is to evaluate the prevalence of CVD risk factors among men ina worker’s cohort with no previous CVD, to study control variations across time and the factors associated with poor control. To this end, we conducted a cohort reexamination (2010–2014) within the context of the Aragon Workers Health Study (AWHS). Data from working characteristics, analytical values and pharmacological prescription were included in the analysis. Prevalences of risk factor diagnosis and control were calculated, as well as factors associated with poor control. The prevalence of CVD risk factors was high. In 2014dyslipidaemia was the most prevalent (85.2%) followed by Hypertension (HT) (42.0%). People under treatment increased for the period analysed (p<0.001). The proportion of people treated varied from 72.2% in Diabetes Mellitus to 31.1% in dyslipidaemia in 2014. 46.2% of the workers with HT were controlled, decreasing to 21.9% in Diabetes and 11.0% in dyslipidaemia (2014). Working in a turn different to central shift was associated with poor control, especially for those working at night with HT (Odds Ratio in 2010: 3.6; Confidence Interval 95% 1.8–7.4) and dyslipidaemia (Odds Ratio 2010: 4.7; Confidence Interval 95% 1.3–16.4). We conclude that, although CVD control has increased significantly for the period studied, there are still many people that do not receive any treatment, and control goals are normally not achieved.
000069936 536__ $$9info:eu-repo/grantAgreement/ES/ISCIII/PI13-01668
000069936 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000069936 590__ $$a2.776$$b2018
000069936 591__ $$aMULTIDISCIPLINARY SCIENCES$$b23 / 69 = 0.333$$c2018$$dQ2$$eT2
000069936 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000069936 700__ $$0(orcid)0000-0002-7194-8275$$aMalo, Sara$$uUniversidad de Zaragoza
000069936 700__ $$0(orcid)0000-0002-2712-6709$$aFeja, Cristina$$uUniversidad de Zaragoza
000069936 700__ $$aLallana, Mª Jesús
000069936 700__ $$aLeón-Latre, Montserrat$$uUniversidad de Zaragoza
000069936 700__ $$0(orcid)0000-0002-9887-2629$$aCasasnovas,  José Antonio$$uUniversidad de Zaragoza
000069936 700__ $$0(orcid)0000-0002-6671-5661$$aRabanaque, Mª José$$uUniversidad de Zaragoza
000069936 700__ $$aGuallar, Eliseo
000069936 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000069936 7102_ $$11008$$2615$$aUniversidad de Zaragoza$$bDpto. Microb.Med.Pr.,Sal.Públ.$$cÁrea Medic.Prevent.Salud Públ.
000069936 773__ $$g13, 2 (2018), 0193541 [12 p.]$$pPLoS One$$tPloS one$$x1932-6203
000069936 8564_ $$s497104$$uhttps://zaguan.unizar.es/record/69936/files/texto_completo.pdf$$yVersión publicada
000069936 8564_ $$s72370$$uhttps://zaguan.unizar.es/record/69936/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000069936 909CO $$ooai:zaguan.unizar.es:69936$$particulos$$pdriver
000069936 951__ $$a2019-07-09-12:36:38
000069936 980__ $$aARTICLE